VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Thyroid Cancer

Brenda Denzler
Cancer survivors worry about recurrence, but seldom think about their risk for new primaries.
Brielle Urciuoli
The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.
Brielle Urciuoli
After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.
Brielle Urciuoli
Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.
Corine Mogenis
How much better can I help people now that I have been through it myself?
Kristie L. Kahl
Patients diagnosed with thyroid cancer before the age of 40 appear to be at the highest risk for age-related diseases, including heart disease and diabetes, compared with their age-matched counterparts.
 
Katie Kosko
Expert discusses three promising options to treat patients with medullary thyroid cancer.
Danielle Bucco
Patients who choose not to have their thyroid cancer treated often have feelings of anxiety and isolation, and are at a risk of disengaging from the health care system because they might not feel supported.
Allie Casey
A recent study found that some late effects are more prevalent in patients who were diagnosed with thyroid cancer before 40 compared to those who were diagnosed at a later age.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable